skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Assignee Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignee Name : INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM}
Total Assignments: 2
Assignment: 1
Reel/Frame:050046/0580   Pages: 4
Recorded: 08/14/2019
Attorney Dkt #:B376105US D37472
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
Exec Dt:
07/17/2019
2
Exec Dt:
07/17/2019
3
Exec Dt:
07/19/2019
4
Exec Dt:
07/17/2019
Assignees
1
43, BVD DU 11 NOVEMBRE 1918
VILLEURBANNE, FRANCE 69100
2
101, RUE DE TOLBIAC
PARIS, FRANCE 75103
3
3, RUE MICHEL ANGE
PARIS, FRANCE 75106
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
16340346
Correspondence name and address
ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM, LLP
2200 PENNSYLVANIA AVE. NW
4TH FLOOR EAST
WASHINGTON, DC 20037
Assignment: 2
Reel/Frame:050154/0854   Pages: 6
Recorded: 08/23/2019
Attorney Dkt #:B376105US D37472
Conveyance: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 050046 FRAME: 0580. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Assignors
1
Exec Dt:
07/17/2019
2
Exec Dt:
07/17/2019
3
Exec Dt:
07/19/2019
Assignees
1
43, BVD DU 11 NOVEMBRE 1918
VILLEURBANNE, FRANCE 69100
2
101, RUE DE TOLBIAC
PARIS, FRANCE 75103
3
3, RUE MICHAEL-ANGE
PARIS, FRANCE 75016
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
16340346
Correspondence name and address
ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM, LLP
2200 PENNSYLVANIA AVE. NW
4TH FLOOR EAST
WASHINGTON, DC 20037

Search Results as of: 06/07/2024 05:03 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT